Gambro

Gambro is a global medical technology company and a leader in the development, manufacturing, and supply of products and therapies for renal and hepatic dialysis, myeloma kidney treatment, and other chronic and acute extracorporeal therapies for patients. Dialysis (kidney) is the world's first extracorporeal therapy (i.e., treatment for organ failure performed outside the body). Dialysis saves the lives of an increasing number of patients each year, and innovation in this field is essential. The only current alternative to kidney dialysis, kidney transplantation, is not a viable option for most patients due to a shortage of donor organs. For decades, Gambro has been the first to market with many groundbreaking innovations. By designing and delivering solutions for dialysis clinics and intensive care units, Gambro not only provides improved treatment quality but also greater efficiency.